查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球弱视治疗设备市场-2022-2029
市场调查报告书
商品编码
1140734

全球弱视治疗设备市场-2022-2029

Global Amblyopia Therapeutic Apparatus Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

世界上不断上升的残疾和失明将推动市场增长。

医疗设备和技术支出的增加推动了市场增长。此外，全球残疾和失明的增加也将推动预测期内的市场增长。例如：根据世界卫生组织 2021 年的数据，全球至少有 22 亿人患有视力障碍或失明，其中至少有 10 亿人患有本可以预防或尚未解决的视力障碍。我知道失明是未经治疗的屈光不正（8840 万）、白内障（9400 万）、青光眼（770 万）、角膜混浊（420 万）、糖尿病视网膜病变（390 万）、沙眼（200 万）和未经治疗的老花眼（8.26 亿）人们）。此外，政府在世界各地治疗儿童和青少年眼病方面的积极举措预计将为未来一段时期的市场增长创造有利可图的机会。

但是，熟练劳动力的短缺阻碍了市场的增长。有重要证据表明闭塞疗法和阿托品可有效治疗弱视。然而，弱视仍然难以诊断，主要是由于依从性问题和遮挡治疗和阿托品处罚期间的护理结果不佳。对高技能专业人员的需求、弱视治疗知识的缺乏以及培训新专业人员的巨大成本限制了市场的增长。

地理渗透。

亚太地区是预测期内的主要地区。

本研究按地区分析了全球弱视治疗设备市场，包括北美、欧洲、亚太地区、南美、中东和非洲。

由于医疗保健支出增加和技术进步，亚太地区已成为全球市场份额较高的领先地区。预计该地区也将在 2020-2026 年的预测期内表现出最高的增长率/复合年增长率。患有弱视的儿童人数不断增长等因素为整个亚太地区的定制医疗弱视治疗设备市场创造了丰厚的增长前景。此外，预计中东和非洲以及南美在预测期内也将以健康的复合年增长率增长。

据估计，北美和欧洲将占据全球市场的很大份额。这些地区对眼科医院的需求正在增加，视力恢復中心的数量也在增加。

竞争格局

弱视治疗设备市场与来自美国、中国和印度等关键地区的主要市场参与者竞争适度。为全球市场增长做出贡献的市场参与者包括广州纺织、广州世佳、西安华亚、深圳艾美迪、广州世正、西安爱乐、中科恆通、北京通明等。领先公司正在为全球弱视治疗设备市场的增长采取新产品引进和扩张战略。 2022 年 1 月，全球医疗保健技术领导者美敦力 (Medtronic) 达成最终协议，收购总部位于波士顿地区的私营医疗技术公司 Affera, Inc.。此次收购将有助于扩大美敦力的心臟消融产品组合，包括首次进入地图和导航，这是增长最快的医疗技术市场之一。 2021 年 10 月，FDA 批准了 Luminopia，这是一种用于改善懒惰儿童视力的数字疗法。 Luminopia One 作为处方疗法，适用于 4 至 7 岁患有弱视和各向异性或轻度斜视的儿童的视力增强。

COVID-19 的影响将对全球弱视治疗设备市场产生负面影响。

由于 COVID-19 的全球负担，预计对医用弱视治疗设备的需求将迅速增长。由于大流行，医疗弱视治疗行业的供应商被迫暂停运营以遵守新的政府法规。此次磨合将对全球医用弱视治疗器械行业的销售流量产生重大影响。

全球弱视治疗设备市场报告包括大约 56 个市场数据表、41 个数字和 170 页

目录

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按产品划分的市场细分
  • 按应用划分的市场细分
  • 按地区划分的市场细分

第 4 章弱视治疗设备市场 - 市场动态

  • 市场影响因素
    • 驱动程序
      • 不断增长的医疗保健支出推动了弱视治疗设备市场的增长。
      • 电子商务行业的需求增加
    • 限制因素
      • 缺乏熟练工人
    • 影响分析

第5章行业分析

  • 波特五力分析
  • 供应链分析
  • 价值链分析
  • PEST 分析
  • 定价分析
  • 监管分析
  • 保险报销分析
  • 未满足的需求
  • 专利趋势

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品分类

  • 颜色/图标设备
  • 综合设备

第 8 章. 按应用程序

  • 眼科医院
  • 视力恢復中心

第 9 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 10 章竞争格局

  • 竞争场景
  • 市场定位/市场份额分析
  • 併购分析

第 11 章弱视治疗设备市场 - 公司简介

  • 广州博士
    • 公司简介
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Medtronic
  • Microlife
  • Guangzhou Shijia
  • Omron
  • Xi'an Huaya
  • Shenzhen ElmmediCare
  • Guangzhou Shizheng
  • Xi'an Aile
  • Zhongke Hengtong
  • Beijing Tongming（List Not Exhaustive）

第12章 重要考察

第13章 DataM

简介目录
Product Code: DMMD3122

Market Overview

Amblyopia Therapeutic Apparatus Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 2.9 % during the forecast period (2022-2029).

Amblyopia therapeutic apparatus is a device used to treat Amblyopia, often referred to as "lazy eye" Amblyopia is reduced vision in one or both eyes owing to abnormal vision production in infancy or childhood. There might not be an apparent issue with the eye in Amblyopia. Vision deficiency happens when the nerve impulses between the brain and the retina are not adequately activated. The brain "learns" to see only fuzzy images of an amblyopia eye, even though glasses are used. Consequently, one eye is favored by the brain, usually due to impaired vision with the other eye. Amblyopia therapeutic apparatus is widely used in homecare, hospitals and ophthalmologic centers. The growth of the amblyopia therapeutic apparatus market is the growing demand for amblyopia therapeutic apparatus due to rising healthcare expenditure and favorable government regulations.

Market Dynamics: The increasing prevalence of impairments or blindness incidence across the globe is driving the market's growth.

Growth in expenditure incurred on healthcare equipment and technology will propel the market's growth. Besides, the increasing prevalence of impairments or blindness across the globe drives the market's growth over the forecast years. For instance: as per World Health Organization 2021, at least 2.2 billion people worldwide have a vision impairment or blindness, of whom at least 1 billion have a vision impairment that could have been prevented or has yet to be addressed. Blindness is due to unaddressed refractive error (88.4 million), cataract (94 million), glaucoma (7.7 million), corneal opacities (4.2 million), diabetic retinopathy (3.9 million), and trachoma (2 million), as well as near vision impairment caused by unaddressed presbyopia (826 million). Also, the favorable government initiatives taken regarding treating several eye diseases in the Children or Adolescents population across the globe are expected to create a lucrative opportunity for the market's growth over the forthcoming period.

However, the lack of a skilled workforce hampers market growth. Significant evidence has emerged for effective treatment of amblyopia, occlusion therapy and atropine. However, amblyopia diagnosis remains difficult, primarily due to compliance problems and sub-optimal care results during occlusion and atropine penalization. The requirement of skilled professionals for advanced technology, lack of knowledge about amblyopia therapeutic and huge costs incurred in training new professionals limit the market growth.

Market Segmentation: The color/Icon apparatus segment is projected to be the market's dominant segment during the forecast period.

Based on the product, the amblyopia therapeutic apparatus market has been classified into Color/Icon apparatus and comprehensive apparatus.

Color/Icon apparatus dominated the global market in 2021, whereas the organic amblyopia therapeutic apparatus is expected to present considerable growth shortly. Color/icon amblyopia therapeutic apparatus is much more appropriate for getting rid of amblyopia. Therefore, the increasing usage of color/Icon Apparatuses in the amblyopia therapeutic apparatus is expected to propel the near future segmental growth.

Amblyopia therapeutic apparatus is segmented based on application, which includes an eye hospital and vision recovery center.

Eye hospital segment held significant market share in global amblyopia therapeutic apparatus market. Most of this amblyopia therapeutic involves the diagnosis and treatment care of the patients for various amblyopia. These services are provided through public or private eye hospitals and clinics. The countries are developing their public and private hospitals to provide better medical treatments to the population. Moreover, the increasing number of overall treatments in hospitals includes procedures including Glasses and eye patches, further driving the market growth. According to the American Academy of Ophthalmology report published in 2021, According to the United States Census Bureau stated, the population of the United States is 289 million; among this, 151 million people require some form of vision correction, and 24% of the population (69 million people) is myopic, and it is estimated that about 43 million of these are candidates for refractive surgery. 60% have less than 2 diopters (D) of myopia, 39% have 2 to 8 D of myopia, and fewer than 1% have more than 8 D of myopia. Approximately 26% of the United States population (75 million people) are hyperopic, but only 15 million of these are candidates for refractive surgery. The average age of refractive surgery patients with myopia is 40 years, and with hyperopia, 55 years.

Geographical Penetration: Asia Pacific is the dominating region during the forecast period.

Based on geography, the study analyzes the amblyopia therapeutic apparatus market globally, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

The Asia Pacific is the leading/significant region globally in terms of market share due to the increasing growth in healthcare expenditure and technological advancement. In comparison, the region is also anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2026. Factors such as the rising population of children suffering from amblyopia would create lucrative growth prospects for the customized medical amblyopia therapeutic apparatus market across the Asia-Pacific region. Moreover, the Middle East & Africa and South America are also expected to grow with a healthy CAGR over the forecast period.

North America and Europe are estimated to hold a significant share in the global market. Increasing demand in eye hospitals across these regions also increases the number of vision recovery centers.

Competitive Landscape:

The amblyopia therapeutic apparatus market is moderately competitive, due to major market players in the key regions such as the US, China, India and others. Market players contributing to the growth of the global market include Guangzhou Boshi, Guangzhou Shijia, Xi'an Huaya, Shenzhen ElmmediCare, Guangzhou Shizheng, Xi'an Aile, Zhongke Hengtong, Beijing Tongming, among others. The major players are adopting new product launches and expansion strategies for global growth in the Amblyopia Therapeutic Apparatus market. In January 2022, Medtronic, a global leader in healthcare technology, has a definitive agreement to acquire Affera, Inc, a Boston area-based, privately held medical technology company. This acquisition helps to expand Medtronic's cardiac ablation portfolio, including first-time entry into mapping and navigation, within one of the fastest-growing MedTech markets. In October 2021, FDA approved Luminopia's digital therapeutic to enhance vision in children with lazy eyes. Luminopia One as a prescription therapy is indicated for enhancement in visual acuity in children with amblyopia aged between four and seven years and associated with anisometropia or mild strabismus.

COVID-19 Impact: Negative impact on the global amblyopia therapeutic apparatus market.

The demand for medical amblyopia therapeutic equipment is projected to expand rapidly due to the global burden of COVID-19. As a result of the pandemic, suppliers of the Medical Amblyopia Therapeutic Apparatus industry were forced to suspend their business operations to comply with the new government regulations. This break-in operation significantly affects the sales flow in the global industry for medical amblyopia.

The global amblyopia therapeutic apparatus market report would provide an access to approximately 56 market data tables, 41 figures and 170 pages

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Amblyopia Therapeutic Apparatus Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing HealthCare Expenditure boosts the market growth for Amblyopia Therapeutic Apparatus.
      • 4.1.1.2. Increasing demand from the e-commerce industry
    • 4.1.2. Restraints:
      • 4.1.2.1. Lack of skilled workforce
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
  • 7.3. Market Attractiveness Index, By Product Segment
    • 7.3.1. Color/Icon Apparatus
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Comprehensive Apparatus

8. By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Eye Hospital
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Vision Recovery Centre

9. By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. The U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. The U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. The Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Amblyopia Therapeutic Apparatus Market- Company Profiles

  • 11.1. Guangzhou Boshi
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. Medtronic
  • 11.3. Microlife
  • 11.4. Guangzhou Shijia
  • 11.5. Omron
  • 11.6. Xi'an Huaya
  • 11.7. Shenzhen ElmmediCare
  • 11.8. Guangzhou Shizheng
  • 11.9. Xi'an Aile
  • 11.10. Zhongke Hengtong
  • 11.11. Beijing Tongming (List Not Exhaustive)

12. Premium Insights

13. DataM Intelligence

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us